Clinical Trial Update: Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration

View source ↗

Summary

The clinical trial NCT02339987 investigating melanoma tumor infiltration has been terminated. Sponsor Saint John's Cancer Institute conducted the termination an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Saint John's Cancer Institute | Conditions: Melanoma | Status: TERMINATED